NovoLog Approved for Pregnant Type 1's

| Apr 17, 2007

On January 30, 2007, the FDA upgraded NovoLog (a fast-acting insulin analog from Novo Nordisk) from Category C to Category B, thereby indicating that NovoLog is safe and effective for pregnant women with type 1 and their unborn children.

The upgrade was based on the largest ever randomized controlled trial of an insulin analog in pregnant women with type 1.  The study, conducted at 63 sites in 18 countries, compared the safety and efficacy of NovoLog versus human regular insulin (HRI) in 322 type 1 pregnant women.  A1Cs and hypoglycemia were comparable between the two insulins. NovoLog showed improved outcomes for mother and child in terms of fewer preterm deliveries, reduced risk of neonatal hypoglycemia, and rates of major hypoglycemia. Risks to the fetus were comparable between the two insulins. 

Click Here To View Or Post Comments

Categories: A1c Test, Childbirth, Insulin, Low Blood Sugar, Novo Nordisk, Pregnancy, Type 1 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Apr 17, 2007

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.